Of potential interest, miR-34a-5p targets MDM4, a p53 regulator that has been found down-regulated in thyroid cancer, with a coupling to advanced stages of the disease (Prodosmo et al. 2008). The gene discussed is TP53; the disease is thyroid gland carcinoma.